Skip to main content
. 2021 Sep 9;48(1):37–46. doi: 10.1093/schbul/sbab106

Table 3.

Clinical and Demographic Predictors of Plasma APRIL in a Subsample of Patients with SCZ, BIP, and MDD (n = 668)

Covariates Standardized Coefficients (Beta) t P-value Adjusted R2
Age −0.04 −0.90 .37 0.007
Sex 0.03 1.65 .10
Ethnicity 0.05 1.39 .17
BMI 0.04 1.05 .29
hsCRP −0.01 −0.35 .73
Smoking status −0.02 −0.46 .65
PANSS positive −0.09 −2.40 .017*
PANSS negative −0.01 −0.30 .77
Antipsychotics (DDD) 0.06 1.51 .13

SCZ, schizophrenia and other nonaffective psychotic disorders; BIP, bipolar spectrum disorder; MDD, major depressive disorder. *P < .05. Stepwise regression analysis was employed; Plasma APRIL, a prroliferation-inducing ligand; Ethnicity, European ethnicity in percent; BMI, body-mass-index, weight/(height)2, (kg/m2); Plasma hsCRP, high sensitivity C-reactive protein; antipsychotics (DDD), prescribed antipsychotics, number of defined daily doses. Smoking status (yes/no), PANSS positive, Positive and Negative Syndrome Scale, positive subscale. PANSS negative, Positive and Negative Syndrome Scale, negative subscale.